|

Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients

RECRUITINGSponsored by Mansoura University Hospital
Actively Recruiting
SponsorMansoura University Hospital
Started2024-07-14
Est. completion2025-09-15
Eligibility
Age40 Years – 70 Years
View on ClinicalTrials.gov →

NCT06518473

Summary

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. The presence of non-fully reversible airflow obstruction (FEV1/FVC \< 0.7 post-bronchodilation) measured by spirometry confirms the diagnosis of COPD

Eligibility

Age: 40 Years – 70 Years
Inclusion Criteria:

* Adults aged 40-70 years diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 criteria

Exclusion Criteria:

* Patients with known allergic diseases before enrollment
* Patients with associated other chronic respiratory disorders
* Patients with significant comorbidities that could influence respiratory function.
* Recent respiratory infections or use of systemic corticosteroids within the last month before enrollment.

Conditions2

COPDChronic Obstructive Pulmonary Disease

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.